DK1411921T4 - Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf - Google Patents

Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf

Info

Publication number
DK1411921T4
DK1411921T4 DK02754918.7T DK02754918T DK1411921T4 DK 1411921 T4 DK1411921 T4 DK 1411921T4 DK 02754918 T DK02754918 T DK 02754918T DK 1411921 T4 DK1411921 T4 DK 1411921T4
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
containing terbinafine
terbinafine
pharmaceutical
Prior art date
Application number
DK02754918.7T
Other languages
English (en)
Other versions
DK1411921T3 (da
Inventor
Rainer Alles
Dieter Becker
Jean-Daniel Bonny
Stefan Hirsch
Oskar Kalb
Ernst Ulrich Koelle
Friedrich Karl Mayer
Anton Stuetz
Anthony Williams
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27256227&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1411921(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0117760A external-priority patent/GB0117760D0/en
Priority claimed from GB0128993A external-priority patent/GB0128993D0/en
Priority claimed from GB0212209A external-priority patent/GB0212209D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1411921T3 publication Critical patent/DK1411921T3/da
Publication of DK1411921T4 publication Critical patent/DK1411921T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
DK02754918.7T 2001-07-20 2002-07-19 Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf DK1411921T4 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0117760A GB0117760D0 (en) 2001-07-20 2001-07-20 Organic compounds
GB0128993A GB0128993D0 (en) 2001-12-04 2001-12-04 Organic compounds
GB0212209A GB0212209D0 (en) 2002-05-27 2002-05-27 Organic compounds
PCT/EP2002/008095 WO2003022267A1 (en) 2001-07-20 2002-07-19 Pharmaceutical compositions containing terbinafin and use thereof

Publications (2)

Publication Number Publication Date
DK1411921T3 DK1411921T3 (da) 2008-04-21
DK1411921T4 true DK1411921T4 (da) 2010-11-08

Family

ID=27256227

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754918.7T DK1411921T4 (da) 2001-07-20 2002-07-19 Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf

Country Status (28)

Country Link
US (2) US20040198838A1 (da)
EP (1) EP1411921B2 (da)
JP (3) JP2005503399A (da)
KR (2) KR100651110B1 (da)
CN (1) CN100358518C (da)
AR (1) AR034813A1 (da)
AT (1) ATE381329T1 (da)
AU (1) AU2002321249B2 (da)
BR (1) BR0211198A (da)
CA (1) CA2453263C (da)
CY (1) CY1107861T1 (da)
DE (1) DE60224194T3 (da)
DK (1) DK1411921T4 (da)
ES (1) ES2295381T5 (da)
HK (1) HK1067299A1 (da)
HU (1) HUP0401200A3 (da)
IL (2) IL159591A0 (da)
MX (1) MXPA04000627A (da)
MY (1) MY136136A (da)
NO (1) NO332268B1 (da)
NZ (1) NZ530648A (da)
PE (1) PE20030287A1 (da)
PL (1) PL365416A1 (da)
PT (1) PT1411921E (da)
RU (1) RU2298402C2 (da)
SI (1) SI1411921T2 (da)
TW (1) TWI302460B (da)
WO (1) WO2003022267A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
JP2005538067A (ja) * 2002-07-02 2005-12-15 ノバルティス アクチエンゲゼルシャフト 副鼻腔炎の処置方法
JP2005060310A (ja) * 2003-08-13 2005-03-10 Towa Yakuhin Kk 不快な味をマスキングする経口投与用製剤
JP2005187339A (ja) * 2003-12-24 2005-07-14 Iwaki Seiyaku Co Ltd 耐光性塩酸テルビナフィンフィルムコート錠
JP4999297B2 (ja) * 2005-08-10 2012-08-15 高田製薬株式会社 高含量塩酸テルビナフィン小型錠剤
US8815285B2 (en) * 2006-03-28 2014-08-26 Wockhardt Ltd. Extended release dosage forms of metoprolol
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
HUE029173T2 (hu) * 2006-04-26 2017-02-28 Alphapharm Pty Ltd Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot
CA2649372A1 (en) * 2006-06-07 2007-12-13 Novartis Ag Process for making multiparticulates using a roller compactor
PT2391345E (pt) * 2009-01-28 2014-12-03 Novartis Ag Formulações galénicas compreendendo aliscireno
WO2010086732A1 (en) * 2009-01-30 2010-08-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Stable compositions for nail and skin treatment
CN102198111A (zh) * 2011-06-17 2011-09-28 哈尔滨乐泰药业有限公司 一种抗真菌药物片剂的制备方法
WO2013043143A1 (ru) * 2011-09-21 2013-03-28 Slyusar Viktor Timopheevich Способ снижения лишнего веса
CA2866276A1 (en) * 2012-03-07 2013-09-12 Santarus, Inc. Controlled-release solid dosage forms of mesalamine
BR112018068665B1 (pt) 2016-03-15 2023-12-26 Acer Therapeutics Inc Composição farmacêutica de fenilbutirato de sódio, método de produção da mesma e seus usos
US11504687B2 (en) 2016-10-11 2022-11-22 Khalifa University of Science and Technology Coated chloride salt particles and methods of making and using the same
CN109833301A (zh) * 2017-11-29 2019-06-04 天津市保灵动物保健品有限公司 一种犬猫用盐酸特比萘芬风味片及其制备工艺
CN109925296B (zh) * 2017-12-19 2021-09-07 四川济生堂药业有限公司 一种中药微丸的包衣方法
CN112156078A (zh) * 2020-11-11 2021-01-01 乐泰药业有限公司 一种盐酸特比萘芬片、其制备方法以及杂质与质量检测方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK62184D0 (da) † 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
US4894375A (en) * 1986-09-29 1990-01-16 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
DE3937455A1 (de) * 1989-11-10 1991-05-16 Nordmark Arzneimittel Gmbh Antacidatabletten
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5234697A (en) * 1992-06-22 1993-08-10 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5415872A (en) * 1992-06-22 1995-05-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing salts of bile acids
US5578304A (en) * 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5332727A (en) * 1993-04-29 1994-07-26 Birkmayer U.S.A. Stable, ingestable and absorbable NADH and NADPH therapeutic compositions
AU1313695A (en) * 1993-12-14 1995-07-03 Sandoz Ltd. Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
GB2290965A (en) * 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
NZ280065A (en) * 1995-09-20 1998-04-27 Apotex Inc Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives
CA2184535C (en) * 1996-08-30 2000-04-18 H. Craig Willis Apparatus and method for separation of solids from liquid
DE19637082A1 (de) * 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
TR199901564T2 (xx) * 1997-01-06 1999-09-21 Pfizer Inc. H�zl� ��z�lebilen ve tat-maskesi sa�layan dozaj ispen�iyari formu.
US6342250B1 (en) * 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
FR2771291B1 (fr) † 1997-11-21 2000-02-25 Ethypharm Lab Prod Ethiques Spheroides, procede de preparation et compositions pharmaceutiques
DE19842753A1 (de) † 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
CA2351720C (en) * 1998-11-25 2006-11-21 Cima Labs Inc. Taste masking rapid release coating system
AU764469B2 (en) † 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6248363B1 (en) † 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CN1116033C (zh) * 1999-07-08 2003-07-30 齐鲁制药厂 一种治疗阴道炎的泡腾片剂及其制法
JP2003506480A (ja) * 1999-08-17 2003-02-18 ノバルテイス・コンシユーマー・ヘルス・エス・アー 急速に溶解する剤形およびその製造方法
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
AU2001239838A1 (en) † 2000-02-24 2001-09-03 Advancis Pharmaceutical Corporation Therapeutic product, use and formulation thereof
DE10017996A1 (de) * 2000-04-11 2001-10-18 Pierre Foss Lamisil-Intervall-System
GB0014448D0 (en) * 2000-06-13 2000-08-09 Novartis Ag Organic compounds
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
WO2004069157A2 (en) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies

Also Published As

Publication number Publication date
CA2453263A1 (en) 2003-03-20
KR100651110B1 (ko) 2006-12-21
EP1411921A1 (en) 2004-04-28
IL159591A (en) 2012-06-28
KR20040028935A (ko) 2004-04-03
SI1411921T1 (sl) 2008-06-30
RU2298402C2 (ru) 2007-05-10
CN1527706A (zh) 2004-09-08
NO332268B1 (no) 2012-08-13
PE20030287A1 (es) 2003-05-06
HUP0401200A2 (hu) 2004-10-28
DK1411921T3 (da) 2008-04-21
KR20060076331A (ko) 2006-07-04
ES2295381T3 (es) 2008-04-16
AR034813A1 (es) 2004-03-17
CN100358518C (zh) 2008-01-02
MY136136A (en) 2008-08-29
US20040198838A1 (en) 2004-10-07
JP2008280351A (ja) 2008-11-20
TWI302460B (en) 2008-11-01
PT1411921E (pt) 2008-03-12
WO2003022267A1 (en) 2003-03-20
BR0211198A (pt) 2004-08-10
CA2453263C (en) 2010-12-07
IL159591A0 (en) 2004-06-01
NO20040254L (no) 2004-03-22
AU2002321249B2 (en) 2005-10-27
EP1411921B1 (en) 2007-12-19
PL365416A1 (en) 2005-01-10
EP1411921B2 (en) 2010-08-18
KR100699958B1 (ko) 2007-03-28
CY1107861T1 (el) 2013-06-19
ATE381329T1 (de) 2008-01-15
HUP0401200A3 (en) 2008-03-28
MXPA04000627A (es) 2004-04-20
DE60224194D1 (de) 2008-01-31
NZ530648A (en) 2007-04-27
HK1067299A1 (en) 2005-04-08
US20080286356A1 (en) 2008-11-20
DE60224194T3 (de) 2011-03-17
SI1411921T2 (sl) 2010-12-31
JP2012136523A (ja) 2012-07-19
RU2004105263A (ru) 2005-04-20
JP2005503399A (ja) 2005-02-03
ES2295381T5 (es) 2011-01-31
DE60224194T2 (de) 2008-12-24

Similar Documents

Publication Publication Date Title
DK1411921T4 (da) Farmaceutiske sammensætninger indeholdende terbinafin og anvendelse deraf
NO20033565D0 (no) Acylerte indanylaminer og deres anvendelse som farmasöytiske midler
HUP0302845A3 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
NO20033384D0 (no) Farmasöytisk formulering
FI20011478A0 (fi) Farmaseuttinen koostumus
NO20033566D0 (no) Acylerte 6,7,8,9-tetrehydro-5H-benzocykloheptenyl-aminer og deres anvendelse som farmasöytiske midler
NO20050830L (no) Acylerte heteroarylkondenserte sykloalkenylaminer og deres anvendelse som farmasoytiske midler
NO20033785L (no) Farmasöytisk formulering
DK1395242T3 (da) Flydende farmaceutisk sammensætning
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
NO20035627D0 (no) Farmasöytisk formulering
EE200300589A (et) Ravimkoostised
GB0108470D0 (en) Pharmaceutical compositions and their use
FI20022128A0 (fi) Farmaseuttinen koostumus
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
DK1429753T3 (da) Farmaceutisk sammensætning omfattende gamma-butyrobetain
DK1482967T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1
DK1680134T3 (da) Sammensætninger og anvendelser deraf
NO20041236L (no) Farmasoytisk formulering
SE0100590D0 (sv) New composition and use
SE0103104D0 (sv) A composition and use thereof